VANCOUVER, BC / ACCESSWIRE / May 17, 2016 / With successful US and Canada launches under its belt, True Leaf International Ltd. (CSE: MJ) (FSE: TLA) will soon offer its True Hemp pet treats for sale in Europe, unveiling the product - ready for sale - at the upcoming Interzoo pet supply exhibition May 26-May 29, in Nuremberg, Germany.
Cannot view this image?
Please visit http://orders.newsfilecorp.com/files/3826/20632_a1463416120184_97.jpg
Interzoo®, the world's largest bi-annual exhibition of supplies for pets, including dogs, cats, horses and birds is renowned for showcasing innovation in the industry. In 2014, more than 37,000 visitors caught up with the latest in pet care at over 1,700 exhibitors from more than 60 countries.
True Leaf's product line, already receiving accolades for its innovative formulation and graphic design in North America, appears to be ideally positioned for the European market. "Europeans have always had an appreciation for high-quality natural products," said Darcy Bomford, True Leaf CEO. "In addition, hemp has been grown in some regions of Europe for generations and we're excited to use European hemp as a key component of our product lines." The company has already seen interest in the product line leading up to the show and expects significant demand as it rolls out across the European Union.
True Leaf has partnered with Pet Horizons to facilitate the True Hemp European launch. With offices in Germany, UK and Spain, Pet Horizons - which has a proven history developing and implementing European sales, marketing and distribution strategies for global brands - will act as the True Leaf sales and marketing team in Europe. "This is an ideal partnership," said Darcy Bomford. "Pet Horizons allows us to expand quickly and effectively to Europe, so that in a relatively short period of time, we're able to serve pet owners across two continents."
Pet Horizons is led by Bob Hanson and Malcolm Elam, each with 25 years consulting experience in the pet industry following careers in sales and marketing with Pedigree-Mars and the Quaker Oats - Pet Division. They are skilled in bringing new brands to market. "We're excited to partner with True Leaf as it launches its product line into Europe," said Bob Hanson. "We think that True Hemp is a unique and innovative product with proven functional ingredients. We look forward to introducing it to European pet owners and we think they'll like it."
For more information about TRUE HEMP™ and True Leaf at Interzoo, please contact:
Alison Ruks
VP of Marketing and Operations
P: 778 475 5323
E: [email protected]
Contact:
Kevin Bottomley
Director
True Leaf Medicine International Ltd
M: +1 778 389 9933
[email protected]
About True Leaf Medicine International Ltd:
True Leaf Medicine International Ltd, through its wholly-owned subsidiary 'True leaf Pet', is entering the $60 billion pet industry with a line of hemp-focused pet treats and supplements marketed through natural pet health and veterinary channels in Canada and the US. The company has also filed an application under Health Canada's Marihuana for Medicinal Purposes Regulations (MMPR) to become a Canadian licensed producer through its 'True Leaf Medicine' subsidiary. It has passed through the preliminary and enhanced screening process of Health Canada's review and is currently awaiting security clearance and 'pre-licensing inspection' approval.
FORWARD LOOKING INFORMATION
This press release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks various risk factors discussed in the Company's Management's Discussion and Analysis under the Company's profile on www.sedar.com. While the Company may elect to, it does not undertake to update this information at any particular time.
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
SOURCE: True Leaf Medicine International Ltd.